Bimodal-hybrid heterocyclic amine targeting oxidative pathways and copper mis-regulation in Alzheimer's disease

Paulina Gonzalez, Viviana C P Da Costa, Kimberly Hyde, Qiong Wu, Onofrio Annunziata, Jose Rizo-Rey, Giridhar Akkaraju, Kayla N. Green

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Oxidative stress resulting from metal-ion misregulation plays a role in the development of Alzheimer's disease (AD). This process includes the production of tissue-damaging reactive oxygen species and amyloid aggregates. Herein we describe the synthesis, characterization and protective capacity of the small molecule, lipoic cyclen, which has been designed to target molecular features of AD. This construct utilizes the biologically compatible and naturally occurring lipoic acid as a foundation for engendering low cellular toxicity in multiple cell lines, radical scavenging capacity, tuning the metal affinity of the parent cyclen, and results in an unexpected affinity for amyloid without inducing aggregation. The hybrid construct thereby shows protection against cell death induced by amyloid aggregates and copper ions. These results provide evidence for the rational design methods used to produce this fused molecule as a potential strategy for the development of lead compounds for the treatment of neurodegenerative disorders.

Original languageEnglish (US)
Pages (from-to)2072-2082
Number of pages11
JournalMetallomics
Volume6
Issue number11
DOIs
StatePublished - Nov 1 2014

ASJC Scopus subject areas

  • Chemistry (miscellaneous)
  • Biophysics
  • Biochemistry
  • Biomaterials
  • Metals and Alloys

Fingerprint

Dive into the research topics of 'Bimodal-hybrid heterocyclic amine targeting oxidative pathways and copper mis-regulation in Alzheimer's disease'. Together they form a unique fingerprint.

Cite this